Robeco Schweiz’s Pfizer PFE Stock Holding History

Robeco Schweiz’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-99,112	Closed	-$3.08M	–	189
2015 Q4	$3.08M	Hold	99,112	–	–	0.26%	111
2015 Q3	$2.92M	Sell	99,112 -71,636	-42%	-$2.3M	0.27%	113
2015 Q2	$5.44M	Sell	170,748 -124,427	-42%	-$4.06M	0.45%	82
2015 Q1	$9.8M	Sell	295,175 -54,226	-16%	-$1.72M	0.77%	36
2014 Q4	$10.4M	Sell	349,401 -256,331	-42%	-$7.35M	0.79%	32
2014 Q3	$17.1M	Buy	605,732 +59,246	+11%	+$1.66M	1.37%	16
2014 Q2	$15.4M	Sell	546,486 -993	-0.2%	-$28.3K	1.25%	14
2014 Q1	$16.6M	Buy	547,479 +12,425	+2%	+$370K	1.44%	14
2013 Q4	$15.6M	Sell	535,054 -156,884	-23%	-$4.57M	1.38%	14
2013 Q3	$19M	Sell	691,938 -85,480	-11%	-$2.33M	1.59%	11
2013 Q2	$20.8M	Buy	+777,418	New	+$21.5M	1.87%	10

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Robeco Schweiz's PFE Position: Q1 2016 in Review

Robeco Schweiz sold out of Pfizer (PFE) in Q1 2016, closing a stake of 99,112 shares — an estimated $3.08M sold.

Robeco Schweiz first reported a position in PFE in Q2 2013 and held it in 11 quarters. The position peaked at $20.8M in Q2 2013. 1,967 funds tracked by Wall St. Rank hold PFE as of Q1 2016.

Robeco Schweiz reported no remaining Pfizer position as of Q1 2016 after selling out during the quarter.
Robeco Schweiz sold 99,112 Pfizer shares in Q1 2016, an estimated $3.08M.
Robeco Schweiz first reported a position in Pfizer in Q2 2013 and held it in 11 quarters.
Robeco Schweiz's Pfizer position peaked at $20.8M in Q2 2013.
1,967 funds tracked by Wall St. Rank held Pfizer as of Q1 2016.

Based on Robeco Schweiz's 13F filing for Q1 2016, filed 18 May 2016.